Form 4: ClearPoint Neuro Director Acquires Shares as Compensation

ClearPoint Neuro Director R. John Fletcher acquired 422 shares of common stock valued at $13.68 per share as part of his compensation plan.

Summary

• R. John Fletcher, a Director of ClearPoint Neuro, Inc. (CLPT), acquired 422 shares of the company's common stock.
• The transaction occurred on January 2, 2026, with shares priced at $13.68 each.
• These shares were issued as payment for fees owed to Mr. Fletcher under the company's Non-Employee Director Compensation Plan.
• The issuance was made pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan.
• Following this acquisition, Mr. Fletcher beneficially owns 116,662 shares of ClearPoint Neuro common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged plan.

Sentiment

Score: 6

Explanation: The acquisition of shares by a director, even as compensation, generally indicates continued alignment of management interests with shareholders, which is a mildly positive signal.

Positives

• Director R. John Fletcher increased his beneficial ownership in ClearPoint Neuro by 422 shares, aligning his interests further with shareholders.
• The transaction is part of a structured compensation plan, indicating a consistent approach to director remuneration.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive sign of commitment and alignment with long-term company performance.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director as part of an existing compensation plan. While it shows continued alignment, it does not present new fundamental information significant enough to alter an investment recommendation based solely on this filing.

Keywords

ClearPoint Neuro, CLPT, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Equity Compensation, R. John Fletcher